1. Home
  2. KNRX vs ECOR Comparison

KNRX vs ECOR Comparison

Compare KNRX & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$0.88

Market Cap

50.5M

Sector

Technology

ML Signal

N/A

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$5.46

Market Cap

52.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
ECOR
Founded
2009
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.5M
52.4M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
KNRX
ECOR
Price
$0.88
$5.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.00
AVG Volume (30 Days)
53.5K
87.1K
Earning Date
06-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,149,328.00
$29,835,000.00
Revenue This Year
N/A
$28.92
Revenue Next Year
N/A
$32.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.90
52 Week Low
$0.78
$4.16
52 Week High
$4.00
$19.49

Technical Indicators

Market Signals
Indicator
KNRX
ECOR
Relative Strength Index (RSI) 34.53 41.53
Support Level $0.78 $5.07
Resistance Level $1.06 $5.73
Average True Range (ATR) 0.24 0.67
MACD -0.03 -0.26
Stochastic Oscillator 11.82 8.36

Price Performance

Historical Comparison
KNRX
ECOR

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: